CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Salt Lake City, UT
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.